Capital Market Strategies’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$298K	Sell	670 -350	-34%	-$161K	0.21%	99
2025 Q1	$495K	Buy	1,020 +20	+2%	+$9.32K	0.33%	60
2024 Q4	$403K	Sell	1,000 -38	-4%	-$17.6K	0.23%	93
2024 Q3	$483K	Buy	1,038 +5	+0.5%	+$2.4K	0.29%	70
2024 Q2	$484K	Sell	1,033 -124	-11%	-$53.8K	0.31%	65
2024 Q1	$484K	Buy	1,157 +207	+22%	+$87.5K	0.37%	61
2023 Q4	$387K	Sell	950 -12	-1%	-$4.43K	0.34%	73
2023 Q3	$332K	Buy	962 +84	+10%	+$29.4K	0.33%	78
2023 Q2	$309K	Buy	+878	New	+$296K	0.29%	89
2023 Q1	–	Sell	-870	Closed	-$251K	–	132
2022 Q4	$251K	Hold	870	–	–	0.27%	104
2022 Q3	$252K	Hold	870	–	–	0.28%	97
2022 Q2	$245K	Hold	870	–	–	0.26%	108
2022 Q1	$227K	Buy	+870	New	+$206K	0.2%	132